Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Recruiting
1,152 enrolled
PROQEM
Active not recruiting
500 enrolled
HELIOPREDICT
Recruiting
700 enrolled
ctDNA for Risk Stratification in Melanoma
Active not recruiting
296 enrolled
SHERLOCK
Recruiting
7,000 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
Completed
25 enrolled 13 charts
iSITE
Completed
58 enrolled
Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
Recruiting
70 enrolled
Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer
Recruiting
346 enrolled
ctDNA in Cutaneous Squamous Cell Carcinoma
Recruiting
60 enrolled
RELI
Not yet recruiting
297 enrolled
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
Completed
24 enrolled
COSMIC
Recruiting
2,000 enrolled
PRO-ACTIVE
Recruiting
850 enrolled
ELEPHAS-04
Recruiting
324 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
Active not recruiting
1,122 enrolled
IMMUMELA
Completed
217 enrolled
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Completed
14 enrolled
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Not yet recruiting
40 enrolled
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Recruiting
12,000 enrolled
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
Active not recruiting
126 enrolled
FIBIOME
Not yet recruiting
60 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
Active not recruiting
12 enrolled
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
Recruiting
1,000 enrolled
OpticSkin
Not yet recruiting
140 enrolled
Pancreas Registry and High Risk Registry
Recruiting
1,368 enrolled
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Active not recruiting
72 enrolled
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
Recruiting
100 enrolled
SJFAMILY
Recruiting
1,500 enrolled
PROMPT
Active not recruiting
42 enrolled
PPIX
Recruiting
125 enrolled
Artificial Intelligence Patient App for RDEB SCCs
Active not recruiting
20 enrolled
Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery
Completed
173 enrolled
EVpredict
Not yet recruiting
378 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
Completed
5 enrolled
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
Recruiting
1,250 enrolled
IMPACT
Recruiting
80 enrolled
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Recruiting
30 enrolled
iCaRe2
Recruiting
999,999 enrolled
Artificial Intelligence Enhanced Optical Coherence Tomography (AI-OCT) Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma
Not yet recruiting
30 enrolled
COPERGRAM1
Not yet recruiting
40 enrolled
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
Recruiting
24 enrolled
DOSCA-2
Enrolling by invitation
2,900 enrolled
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Active not recruiting
6,000 enrolled
Institutional Registry of Rare Diseases
Recruiting
380 enrolled
Precision Medicine for Neurocutaneous Syndromes in Western China
Completed
1,200 enrolled